The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Global statistics on alcohol, tobacco and illicit drug use: 2017 status report
Open accessAbstract
Aims: This review provides an up‐to‐date curated source of information on alcohol, tobacco and illicit drug use and their associated mortality and burden of disease. Limitations in the data are also discussed, including how these can be addressed in the future. Methods: Online data sources were identified through expert review. Data were obtained mainly from the World Health Organization, United Nations Office on Drugs and Crime and Institute for Health Metrics and Evaluation. Results: In 2015, the estimated prevalence among the adult population was 18.4% for heavy episodic alcohol use (in the past 30 days); 15.2% for daily tobacco smoking; and 3.8, 0.77, 0.37 and 0.35% for past‐year cannabis, amphetamine, opioid and cocaine use, respectively. European regions had the highest prevalence of heavy episodic alcohol use and daily tobacco use. The age‐standardized prevalence of alcohol dependence was 843.2 per 100 000 people; for cannabis, opioids, amphetamines and cocaine dependence it was 259.3, 220.4, 86.0 and 52.5 per 100 000 people, respectively. High‐income North America region had among the highest rates of cannabis, opioid and cocaine dependence. Attributable disability‐adjusted life‐years (DALYs) were highest for tobacco smoking (170.9 million DALYs), followed by alcohol (85.0 million) and illicit drugs (27.8 million). Substance‐attributable mortality rates were highest for tobacco smoking (110.7 deaths per 100 000 people), followed by alcohol and illicit drugs (33.0 and 6.9 deaths per 100 000 people, respectively). Attributable age‐standardized mortality rates and DALYs for alcohol and illicit drugs were highest in eastern Europe; attributable age‐standardized tobacco mortality rates and DALYs were highest in Oceania. Conclusions: In 2015 alcohol use and tobacco smoking use between them cost the human population more than a quarter of a billion disability‐adjusted life years, with illicit drugs costing further tens of millions. Europeans suffered proportionately more, but in absolute terms the mortality rate was greatest in low‐ and middle‐income countries with large populations and where the quality of data was more limited. Better standardized and rigorous methods for data collection, collation and reporting are needed to assess more accurately the geographical and temporal trends in substance use and its disease burden.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lim, S. S., Vos, T., Flaxman, A. D., Danaei, G., Shibuya, K., Adair-Rohani, H., AlMazroa, M. A., Amann, M., Anderson, H. R., Andrews, K. G., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61766-8 · Cited by 11,805
Self-citationWang, H., Naghavi, M., Allen, C., Barber, R. M., Bhutta, Z. A., Carter, A., Casey, D. C., Charlson, F. J., Chen, A. Z., Coates, M. M., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31012-1 · Cited by 6,596
Self-citationTransforming our world: the 2030 Agenda for Sustainable Development
(2022) · Sustainable Development Goals · doi:10.5040/9781509934058.0025 · Cited by 6,562
The Health consequences of smoking—50 years of progress : a report of the Surgeon General
Lushniak, B. D., Samet, J. M., Pechacek, T. F., Norman, L., & Taylor, P. A. (2014) · Cited by 4,990
Rehm, J., Mathers, C., Popova, S., Thavorncharoensap, M., Teerawattananon, Y., & Patra, J. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60746-7 · Cited by 3,870
Self-citationGeneral, U. S. S. (2014) · PsycEXTRA Dataset · doi:10.1037/e510072014-001 · Cited by 3,324
Ezzati, M., López, A. D., Rodgers, A., & Murray, C. J. L. (2004) · Cited by 3,319
Kassebaum, N. J., Arora, M., Barber, R. M., Bhutta, Z. A., Brown, J., Carter, A., Casey, D. C., Charlson, F. J., Coates, M. M., Coggeshall, M., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31460-x · Cited by 2,163
Self-citationReitsma, M. B., Fullman, N., Ng, M., Salama, J. S., Abajobir, A., Abate, K. H., Abbafati, C., Abera, S. F., Abraham, B., Abyu, G. Y., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30819-x · Cited by 2,028
Self-citationDegenhardt, L., Peacock, A., Colledge, S., Leung, J., Grebely, J., Vickerman, P., Stone, J., Cunningham, E. B., Trickey, A., Dumchev, K., et al. (2017) · The Lancet Global Health · doi:10.1016/s2214-109x(17)30375-3 · Cited by 1,429
Self-citationExtent of illicit drug use and dependence, and their contribution to the global burden of disease
Degenhardt, L., & Hall, W. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61138-0 · Cited by 1,303
Self-citationThe relationship between different dimensions of alcohol use and the burden of disease—an update
Rehm, J., Gmel, G. E., Gmel, G., Hasan, O. S. M., Imtiaz, S., Popova, S., Probst, C., Roerecke, M., Room, R., Samokhvalov, A. V., et al. (2017) · Addiction · doi:10.1111/add.13757 · Cited by 1,204
Self-citationComparative quantification of health risks conceptual framework and methodological issues
Murray, C. J., Ezzati, M., Lopez, A. D., Rodgers, A., & Vander Hoorn, S. (2003) · Population Health Metrics · doi:10.1186/1478-7954-1-1 · Cited by 887
Giovino, G. A., Mirza, S. A., Samet, J. M., Gupta, P. C., Jarvis, M. J., Bhala, N., Peto, R., Zatonski, W., Hsia, J., Morton, J., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61085-x · Cited by 740
Self-citationESPAD report 2015 results from the European School Survey Project on Alcohol and Other Drugs.
Kraus, L., Guttormsson, U., Leifman, H., Arpa, S., Molinaro, S., Monshouwer, K., Trapencieris, M., Vicente, J., Arnarsson, Á. M., Balakireva, O. M., et al. (2016) · KTH Publication Database DiVA (KTH Royal Institute of Technology) · doi:10.2810/022073 · Cited by 619
Gmel, G., & Rehm, J. (2004) · Contemporary Drug Problems · doi:10.1177/009145090403100304 · Cited by 466 · cited 1×
“For example, there is greater geographical coverage in estimates of alcohol use because consumption can bemonitored more effectively via surveys [24], and taxation, production, import and export data are available to produce estimates of consumption [25].”
BackgroundSelf-citationLarney, S., Peacock, A., Leung, J., Colledge, S., Hickman, M., Vickerman, P., Grebely, J., Dumchev, K. V., Griffiths, P., Hines, L., et al. (2017) · The Lancet Global Health · doi:10.1016/s2214-109x(17)30373-x · Cited by 422
Self-citationGlobal statistics on addictive behaviours: 2014 status report
Gowing, L. R., Ali, R. L., Allsop, S., Marsden, J., Turf, E. E., West, R., & Witton, J. (2015) · Addiction · doi:10.1111/add.12899 · Cited by 410
Self-citationA generic model for the assessment of disease epidemiology: the computational basis of DisMod II
Barendregt, J. J., van Oortmarssen, G. J., Vos, T., & Murray, C. J. (2003) · Population Health Metrics · doi:10.1186/1478-7954-1-4 · Cited by 402
Ort, C., van Nuijs, A. L. N., Berset, J., Bijlsma, L., Castiglioni, S., Covaci, A., de Voogt, P., Emke, E., Fatta‐Kassinos, D., Griffiths, P., et al. (2014) · Addiction · doi:10.1111/add.12570 · Cited by 394
Self-citationSmoking cessation and smoking patterns in the general population: a 1‐year follow‐up
West, R., McEwen, A., Bolling, K., & Owen, L. (2001) · Addiction · doi:10.1046/j.1360-0443.2001.96689110.x · Cited by 304
Self-citationGravely, S., Giovino, G. A., Craig, L., Commar, A., D'Espaignet, E. T., Schotte, K., & Fong, G. T. (2017) · The Lancet Public Health · doi:10.1016/s2468-2667(17)30045-2 · Cited by 260
Self-citationRehm, J., Kehoe, T., Gmel, G., Stinson, F., Grant, B., & Gmel, G. (2010) · Population Health Metrics · doi:10.1186/1478-7954-8-3 · Cited by 207
Self-citationRehm, J., Kailasapillai, S., Larsen, E., Rehm, M. X., Samokhvalov, A. V., Shield, K. D., Roerecke, M., & Lachenmeier, D. W. (2014) · Addiction · doi:10.1111/add.12498 · Cited by 192 · cited 1×
“However, unrecorded consumption, which is estimated to account for about 25% of all alcohol use globally, introduces marked measurement error (21).”
Self-citationCorrected US opioid‐involved drug poisoning deaths and mortality rates, 1999–2015
Ruhm, C. J. (2018) · Addiction · doi:10.1111/add.14144 · Cited by 169
Assessing the public health impacts of legalizing recreational cannabis use in the USA
Hall, W., & Weier, M. (2015) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.110 · Cited by 159
Self-citationLarance, B., Degenhardt, L. J., Lintzeris, N., WINSTOCK, A. R., & Mattick, R. P. (2011) · Drug and Alcohol Review · doi:10.1111/j.1465-3362.2010.00283.x · Cited by 136
Self-citationUnited Nations Office on Drugs and Crime (2017) · World drug report · doi:10.18356/c595e10f-en · Cited by 131
Lai, F. Y., Bruno, R., Hall, W., GARTNER, C. E., Ort, C., Kirkbride, K. P., Prichard, J., Thai, P. K., Carter, S., & Mueller, J. F. (2012) · Addiction · doi:10.1111/add.12006 · Cited by 121
Self-citationde Savigny, D., Riley, I. D., Chandramohan, D., Odhiambo, F., Nichols, E. K., Notzon, S., AbouZahr, C., Mitra, R. G., Muñoz, D. C., Firth, S., et al. (2017) · Global Health Action · doi:10.1080/16549716.2017.1272882 · Cited by 99
Jones, H. E., Hickman, M., Welton, N. J., Angelis, D. D., Harris, R., & Ades, A. E. (2014) · American Journal of Epidemiology · doi:10.1093/aje/kwu056 · Cited by 55
Self-citationWesson, P., Reingold, A. L., & McFarland, W. (2017) · AIDS and Behavior · doi:10.1007/s10461-017-1678-9 · Cited by 45
Research works printed but not linked: 14
- 10.1097/COH.0000000000000041 · doi:10.1097/coh.0000000000000041
- European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), 2011, Responding to New Psychoactive Substances
- European Monitoring Centre for Drugs and Drug Addiction, 2017, European Drug Report 2017: Trends and Developments.
- 10.1016/S2215-0366(16)30405-9 · doi:10.1016/s2215-0366(16)30405-9
- World Health Organization (WHO), 2016, Global Information System on Alcohol and Health (GISAH)
- Institute for Health Metrics and Evaluation, 2016, GBD Results Tool
- American Psychiatric Association (APA), 2000, Diagnostic and Statistical Manual of Mental Disorders (DSM‐IV‐TR).
- World Health Organization (WHO), 1993, The ICD‐10 Classification of Mental and Behavioural Disorders—Diagnostic Criteria for Research
- Flaxman A. D., 2015, An Integrative Metaregression Framework for Descriptive Epidemiology
- Joint United Nations Programme on HIV/AIDS, 2014, 90‐90‐90: An Ambitious Treatment Target to Help End the AIDS Epidemic
- 10.1111/add.12185 · doi:10.1111/add.12185
- Institute for Health Metrics and Evaluation (IHME), 2015, A Protocol for the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD)
- United Nations Office on Drugs and Crime (UNODC), 2017, Methodology—World Drug Report 2017., 10.18356/c595e10f-en · DOI
- International Agency for Research on Cancer, 2008, IARC Handbooks of Cancer Prevention: Tobacco Control. Volume 12. Methods for Evaluating Tobacco Control Policies
Cited by
Feinstein, M. J., Hsue, P. Y., Benjamin, L. A., Bloomfield, G. S., Currier, J. S., Freiberg, M. S., Grinspoon, S. K., Levin, J., Longenecker, C. T., Post, W. S., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000695 · Cited by 658
Cannabis use and cannabis use disorder
Connor, J. P., Stjepanović, D., Le Foll, B., Hoch, E., Budney, A. J., & Hall, W. D. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00247-4 · Cited by 552
Epidemiological Features of Cardiovascular Disease in Asia
Zhao, D. (2021) · JACC: Asia · doi:10.1016/j.jacasi.2021.04.007 · Cited by 476
Hall, W., Stjepanović, D., Caulkins, J., Lynskey, M., Leung, J., Campbell, G., & Degenhardt, L. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31789-1 · Cited by 357
Self-citationThe COVID-19 pandemic and its impact on substance use: Implications for prevention and treatment
Ornell, F., Moura, H. F., Scherer, J. N., Pechansky, F., Kessler, F. H. P., & von Diemen, L. (2020) · Psychiatry Research · doi:10.1016/j.psychres.2020.113096 · Cited by 308
Metadata
- Authors
- Peacock, A., Leung, J., Larney, S., Colledge, S., Hickman, M., Rehm, J., Giovino, G. A., West, R., Hall, W., Griffiths, P., Ali, R., Gowing, L., Marsden, J., Ferrari, A. J., Grebely, J., Farrell, M., & Degenhardt, L.
- Venue
- Addiction
- Publisher
- Wiley
- Published
- 2018-06-04
- Volume
- 113
- Issue
- 10
- Pages
- 1905-1926
- ISSN
- 0965-2140 (ISSN-L)
- 1360-0443
- OpenAlex
- W2799505340
- Cited by
- 1,038
- References
- 32
- FWCI
- 66.99
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.